The present invention relates to a method for the production of ergosta-5,7-dienol and/or its biosynthetic intermediates and/or metabolites by culturing genetically modified organisms, and to the genetically modified organisms, in particular yeasts, themselves.

 
Web www.patentalert.com

< Compositions and methods for screening anti-cancer agents in yeast

> Methods for drug discovery, disease treatment, and diagnosis using metabolomics

> Compounds useful as pesticides
~ 00532